Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim A Lennox

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|September 1, 2020
Tips for Successful lncRNA Knockdown Using GapmersKim A Lennox, Mark A Behlke
Pharmaceutical Research|April 29, 2010
A direct comparison of anti-microRNA oligonucleotide potencyKim A Lennox, Mark A Behlke
Nucleic Acids Research|November 19, 2015
Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotidesKim A Lennox, Mark A Behlke
Methods in Molecular Biology (Clifton, N.J.)|February 2, 2020
Chemical Modifications in RNA Interference and CRISPR/Cas Genome Editing ReagentsKim A Lennox, Mark A Behlke
Methods in Molecular Biology (Clifton, N.J.)|August 28, 2025
Chemical Modifications in Nucleic Acid TherapeuticsKim A Lennox, Rebecca C Young, Mark A Behlke
Methods in Molecular Biology (Clifton, N.J.)|December 8, 2016
Non-nucleotide Modification of Anti-miRNA OligonucleotidesKim A Lennox, Christopher A Vakulskas, Mark A Behlke
Molecular Therapy. Nucleic Acids|January 10, 2013
In vivo SELEX for Identification of Brain-penetrating AptamersCongsheng Cheng, Yong Hong Chen, Kim A Lennox, et al.
Plos One|October 6, 2015
Antisense Oligonucleotide-Mediated Transcript Knockdown in ZebrafishAndrea Pauli, Tessa G Montague, Kim A Lennox, et al.
Molecular Therapy. Nucleic Acids|August 29, 2013
Improved Performance of Anti-miRNA Oligonucleotides Using a Novel Non-Nucleotide ModifierKim A Lennox, Richard Owczarzy, Derek M Thomas, et al.
Neurobiology of Disease|April 16, 2013
RNAi or overexpression: alternative therapies for Spinocerebellar Ataxia Type 1Megan S Keiser, James C Geoghegan, Ryan L Boudreau, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|September 1, 2020
Tips for Successful lncRNA Knockdown Using GapmersKim A Lennox, Mark A Behlke
Pharmaceutical Research|April 29, 2010
A direct comparison of anti-microRNA oligonucleotide potencyKim A Lennox, Mark A Behlke
Nucleic Acids Research|November 19, 2015
Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotidesKim A Lennox, Mark A Behlke
Methods in Molecular Biology (Clifton, N.J.)|February 2, 2020
Chemical Modifications in RNA Interference and CRISPR/Cas Genome Editing ReagentsKim A Lennox, Mark A Behlke
Methods in Molecular Biology (Clifton, N.J.)|August 28, 2025
Chemical Modifications in Nucleic Acid TherapeuticsKim A Lennox, Rebecca C Young, Mark A Behlke
Methods in Molecular Biology (Clifton, N.J.)|December 8, 2016
Non-nucleotide Modification of Anti-miRNA OligonucleotidesKim A Lennox, Christopher A Vakulskas, Mark A Behlke
Molecular Therapy. Nucleic Acids|January 10, 2013
In vivo SELEX for Identification of Brain-penetrating AptamersCongsheng Cheng, Yong Hong Chen, Kim A Lennox, et al.
Plos One|October 6, 2015
Antisense Oligonucleotide-Mediated Transcript Knockdown in ZebrafishAndrea Pauli, Tessa G Montague, Kim A Lennox, et al.
Molecular Therapy. Nucleic Acids|August 29, 2013
Improved Performance of Anti-miRNA Oligonucleotides Using a Novel Non-Nucleotide ModifierKim A Lennox, Richard Owczarzy, Derek M Thomas, et al.
Neurobiology of Disease|April 16, 2013
RNAi or overexpression: alternative therapies for Spinocerebellar Ataxia Type 1Megan S Keiser, James C Geoghegan, Ryan L Boudreau, et al.
Pageof 3